Scriba, Peter Christian and Beckers, C. and Bürgi, H. and Escobar del Rey, F. and Gembicki, M. and Koutras, D. A. and Lamberg, B. A. and Langer, P. and Lazarus, J. H. and Querido, A. and Thilly, C. and Vigneri, R.
Goitre and Iodine Deficiency in Europe.
In: The Lancet, Vol. 325, No. 8441: pp. 1289-1293
The prevalence of endemic iodine-deficiency goitre in Europe has been reduced in many areas by the introduction of iodination programmes. Recent reports, however, show that goitre remains a significant problem and that its prevalence has not decreased in a number of European countries. Hetzel1 has pointed out that the high global prevalence of iodine-deficiency disorders could be eradicated within 5-10 years by introduction of an iodised salt programme. The current World Health Organisation recommendations for iodine intake are between 150 and 300 μg/day